EPM
AGN

Equitec Proprietary Markets’s Allergan plc AGN Stock Holding History

Equitec Proprietary Markets’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,480
Closed -$1.36M – 122
2016
Q4 		$1.36M Buy
6,480
+4,680
+260% +$969K 0.05% 45
2016
Q3 		$415K Buy
1,800
+1,700
+1,700% +$415K 0.02% 75
2016
Q2 		$23K Buy
+100
New +$23.1K ﹤0.01% 127
2015
Q2 		– Sell
-9,870
Closed -$2.94M – 173
2015
Q1 		$2.94M Buy
9,870
+7,213
+271% +$2.06M 0.23% 37
2014
Q4 		$684K Buy
+2,657
New +$664K 0.03% 128

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Equitec Proprietary Markets's AGN Position: Q1 2017 in Review

Equitec Proprietary Markets sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 6,480 shares — an estimated $1.36M sold.

Equitec Proprietary Markets first reported a position in AGN in Q4 2014 and held it in 5 quarters. The position peaked at $2.94M in Q1 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Equitec Proprietary Markets reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Equitec Proprietary Markets sold 6,480 Allergan plc shares in Q1 2017, an estimated $1.36M.
  • Equitec Proprietary Markets first reported a position in Allergan plc in Q4 2014 and held it in 5 quarters.
  • Equitec Proprietary Markets's Allergan plc position peaked at $2.94M in Q1 2015.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Equitec Proprietary Markets's 13F filing for Q1 2017, filed 24 Apr 2017.